3 employees
Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.
2018
$5M
from 2 investors over 2 rounds
Myosana Therapeutics, Inc raised $5M on December 7, 2022
Investors: Parent Project Muscular Dystrophy
Myosana Therapeutics, Inc raised $351K on August 26, 2021